Written and maintained by CASRAI Editorial Board
Published
On this page
General product information from an FDA clearance record. It is not medical advice and does not interpret any individual result.
Short answer
The Cholestech LDX System is a small, portable analyzer used with single-use test cassettes that measure total cholesterol, HDL cholesterol, triglycerides and glucose in whole blood. FDA 510(k) K223179, decided 2023-09-20 for Alere San Diego, Inc., lists six cassette configurations. LDL and non-HDL cholesterol are calculated estimates, not direct measurements.
Definition and scope
The FDA indications-for-use form describes the system as “a small, portable analyzer and test cassette system” for in vitro diagnostic use only, not to be used for testing children under 2 years. It consists of the Cholestech LDX Analyzer plus cassettes. The submission was a dual submission: a 510(k) (K223179) filed together with a CLIA waiver application (CW220017). For the general idea of this device category, see what an in vitro diagnostic is and point-of-care testing.
How it works
According to the 510(k) summary (prepared 1 September 2023), the sample is whole blood from a fingerstick, collected in a lithium heparin-coated capillary tube, or from venipuncture. It is applied to the cassette, and the cassette is placed in the analyzer. Inside the cassette:
- Plasma is separated from the blood cells.
- Part of the plasma goes to the total cholesterol and triglyceride reaction pads.
- Another part has LDL and VLDL precipitated with dextran sulfate (50,000 MW) and magnesium acetate; the filtrate, containing HDL cholesterol and glucose, goes to the HDL and glucose pads.
Total and HDL cholesterol are read by an enzymatic method (cholesterol esterase, cholesterol oxidase, peroxidase) that forms a purple quinoneimine dye. Triglycerides use lipase, glycerol kinase and glycerol phosphate oxidase, and glucose uses glucose oxidase, with the same colour reaction. Every colour is measured by reflectance photometry. A brown magnetic stripe on each cassette carries the calibration information the analyzer uses to convert the reflectance reading to concentrations.
Cassette configurations
The indications form lists these six cassettes. All are for quantitative determination in whole blood.
| Cassette | Measured | Also reported |
|---|---|---|
| Lipid Profile-GLU | Total cholesterol, HDL, triglycerides, glucose | TC/HDL ratio, estimated LDL, non-HDL |
| TC-HDL-GLU | Total cholesterol, HDL, glucose | None listed |
| TC-GLU | Total cholesterol, glucose | None listed |
| Lipid Profile | Total cholesterol, HDL, triglycerides | TC/HDL ratio, estimated LDL, non-HDL |
| TC-HDL | Total cholesterol, HDL | None listed |
| TC | Total cholesterol | None listed |
Reading the FDA clearance record: a checklist
The clearance shows how FDA classified each function. Read it with the 510(k) summary guide and the FDA 510(k) data guide.
| Product code | Class | Regulation (21 CFR) | Function |
|---|---|---|---|
| CGA | II | 862.1345 (glucose test system) | Primary code on the decision letter |
| CHH | I | 862.1175 | Cholesterol |
| JGY | I | 862.1705 | Triglycerides |
| LBS | I | 862.1475 | Lipoprotein |
| JJE | I | 862.2160 | Discrete photometric chemistry analyzer |
The predicate is the earlier Cholestech LDX System, K120615 (a software update adding a humidity sensor). The summary traces the lineage: the original lipid monitoring system under K901900, glucose, HDL and triglycerides under K932727, and multianalyte controls and calibration verification materials under K102700. Product codes, class and predicate are the fields to compare when two records seem to describe the same device.
Where it matters for labs and clinics
A CLIA waiver application was submitted with the 510(k), so waived-test status is part of the record; see CLIA-waived test and CLIA-waived point-of-care testing for what waiver means for a site. The summary also states the labeling warning that all blood samples, containers, capillary tubes and materials that contact blood should be handled as capable of transmitting infectious disease and discarded in biohazardous waste. Which cassettes an analyzer supports, and the assay menu in current use, should be taken from the current package insert for the cassette lot in hand.
Common misunderstandings
- LDL is measured. In this system, estimated LDL, non-HDL and the TC/HDL ratio are calculated from measured total cholesterol, HDL and triglycerides. Cassettes without triglycerides do not report them.
- Every cassette measures glucose. Only three of the six configurations include glucose.
- The clearance covers every Cholestech assay ever sold. K223179 covers the six cassettes above. Older, separate clearances exist for other analytes under Cholestech Corp in the openFDA database.
- Clearance is an endorsement. FDA states that a substantial equivalence decision does not mean FDA has determined compliance with other requirements of the Act or other federal statutes.
FAQ
What does the Cholestech LDX measure?
Total cholesterol, HDL cholesterol, triglycerides and glucose in whole blood, depending on the cassette. It also reports a TC/HDL ratio and estimated LDL and non-HDL cholesterol on the lipid profile cassettes.
What sample type does it use?
Whole blood from a fingerstick collected in a lithium heparin-coated capillary tube, or from venipuncture, per the 510(k) summary.
Who made it, and which FDA record covers it?
Alere San Diego, Inc. is the applicant on K223179, decided 2023-09-20.
Sources
- FDA 510(k) K223179 decision letter, indications for use and 510(k) summary: accessdata.fda.gov/cdrh_docs/pdf22/K223179.pdf (read 2026-11-12).
- openFDA device 510(k) and classification records for K223179 and product code CGA: open.fda.gov/apis/device/510k (read 2026-11-12).







